Morgan Stanley
IBDQ

Morgan Stanley’s iShares iBonds Dec 2025 Term Corporate ETF IBDQ Stock Holding History

Morgan Stanley’s Portfolio IBDQ Stock Details IBDQ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-3,212,382
Closed -$80.9M – 8330
2025
Q3 		$80.9M Sell
3,212,382
-573,177
-15% -$14.4M ﹤0.01% 1596
2025
Q2 		$95.3M Buy
3,785,559
+183
+0% +$4.6K 0.01% 1362
2025
Q1 		$95.2M Sell
3,785,376
-324,963
-8% -$8.16M 0.01% 1282
2024
Q4 		$103M Buy
4,110,339
+426,159
+12% +$10.7M 0.01% 1234
2024
Q3 		$92.5M Buy
3,684,180
+263,242
+8% +$6.57M 0.01% 1305
2024
Q2 		$85M Buy
3,420,938
+152,048
+5% +$3.77M 0.01% 1297
2024
Q1 		$81.1M Sell
3,268,890
-4,458,284
-58% -$110M 0.01% 1337
2023
Q4 		$191M Buy
7,727,174
+4,310,171
+126% +$106M 0.01% 1182
2023
Q3 		$83.3M Buy
3,417,003
+230,562
+7% +$5.62M 0.01% 1181
2023
Q2 		$77.7M Buy
3,186,441
+495,939
+18% +$12.1M 0.01% 1247
2023
Q1 		$66M Buy
2,690,502
+625,840
+30% +$15.3M 0.01% 1312
2022
Q4 		$50.2M Buy
2,064,662
+338,015
+20% +$8.19M 0.01% 1493
2022
Q3 		$41.7M Sell
1,726,647
-12,842
-0.7% -$317K 0.01% 1465
2022
Q2 		$43M Sell
1,739,489
-103,760
-6% -$2.58M 0.01% 1495
2022
Q1 		$46.5M Sell
1,843,249
-207,595
-10% -$5.36M 0.01% 1349
2021
Q4 		$54.2M Sell
2,050,844
-75,089
-4% -$2M 0.01% 1283
2021
Q3 		$57.1M Buy
2,125,933
+216,625
+11% +$5.84M 0.01% 1207
2021
Q2 		$51.5M Buy
1,909,308
+2,037
+0.1% +$55K 0.01% 1287
2021
Q1 		$51.2M Buy
1,907,271
+29,853
+2% +$808K 0.01% 1161
2020
Q4 		$51.4M Buy
1,877,418
+412,525
+28% +$11.2M 0.01% 1085
2020
Q3 		$39.7M Buy
1,464,893
+207,811
+17% +$5.64M 0.01% 1030
2020
Q2 		$33.9M Buy
1,257,082
+178,866
+17% +$4.69M 0.01% 1066
2020
Q1 		$26.9M Buy
1,078,216
+122,731
+13% +$3.16M 0.01% 1084
2019
Q4 		$24.8M Buy
955,485
+93,387
+11% +$2.42M 0.01% 1470
2019
Q3 		$22.3M Buy
862,098
+76,263
+10% +$1.96M 0.01% 1410
2019
Q2 		$20.1M Buy
785,835
+240,676
+44% +$6.02M 0.01% 1483
2019
Q1 		$13.6M Sell
545,159
-12,558
-2% -$305K ﹤0.01% 1748
2018
Q4 		$13.2M Buy
557,717
+105,861
+23% +$2.5M ﹤0.01% 1830
2018
Q3 		$10.8M Buy
451,856
+89,499
+25% +$2.15M ﹤0.01% 2328
2018
Q2 		$8.67M Buy
362,357
+72,145
+25% +$1.73M ﹤0.01% 2526
2018
Q1 		$7.04M Buy
290,212
+31,542
+12% +$771K ﹤0.01% 2678
2017
Q4 		$6.47M Buy
258,670
+38,497
+17% +$965K ﹤0.01% 2801
2017
Q3 		$5.54M Buy
220,173
+558
+0.3% +$14K ﹤0.01% 2860
2017
Q2 		$5.49M Buy
219,615
+7,143
+3% +$178K ﹤0.01% 2741
2017
Q1 		$5.24M Buy
212,472
+26,441
+14% +$648K ﹤0.01% 2815
2016
Q4 		$4.53M Buy
186,031
+14,557
+8% +$362K ﹤0.01% 3104
2016
Q3 		$4.39M Buy
171,474
+23,529
+16% +$603K ﹤0.01% 2790
2016
Q2 		$3.79M Buy
147,945
+102,015
+222% +$2.56M ﹤0.01% 2863
2016
Q1 		$1.14M Buy
45,930
+40,356
+724% +$977K ﹤0.01% 3832
2015
Q4 		$134K Buy
+5,574
New +$134K ﹤0.01% 5264

Other funds holding IBDQ

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Mercer Global Advisors
Mercer Global Advisors Denver, Colorado $67.6B AUM 18.3% 1-Year Est. Return
BL
Balentine LLC Atlanta, Georgia $2.48B AUM 17.44% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Morgan Stanley's IBDQ Position: Q4 2025 in Review

Morgan Stanley sold out of iShares iBonds Dec 2025 Term Corporate ETF (IBDQ) in Q4 2025, closing a stake of 3,212,382 shares — an estimated $80.9M sold.

Morgan Stanley first reported a position in IBDQ in Q4 2015 and held it in 40 quarters. The position peaked at $191M in Q4 2023. 3 funds tracked by Wall St. Rank hold IBDQ as of Q4 2025.

  • Morgan Stanley reported no remaining iShares iBonds Dec 2025 Term Corporate ETF position as of Q4 2025 after selling out during the quarter.
  • Morgan Stanley sold 3,212,382 iShares iBonds Dec 2025 Term Corporate ETF shares in Q4 2025, an estimated $80.9M.
  • Morgan Stanley first reported a position in iShares iBonds Dec 2025 Term Corporate ETF in Q4 2015 and held it in 40 quarters.
  • Morgan Stanley's iShares iBonds Dec 2025 Term Corporate ETF position peaked at $191M in Q4 2023.
  • 3 funds tracked by Wall St. Rank held iShares iBonds Dec 2025 Term Corporate ETF as of Q4 2025.

Based on Morgan Stanley's 13F filing for Q4 2025, filed 13 Feb 2026.